Venture-Backed Startups

EPIC iO provides an AI-powered IoT data analytics platform called DeepInsights that helps businesses extract and analyze real-time insights from IoT devices for data-driven decision-making. The company serves enterprises seeking to enhance connectivity, safety, and operational intelligence through 5G-ready and AI-enabled solutions.

1 investor

Epico Play develops white-label digital solutions including mobile apps, websites, and e-commerce platforms for sports brands and entertainment companies. The company offers fan engagement tools, CRM capabilities, editorial content management, and advertising space monetization.

1 investor

Epicor provides ERP and industry-specific software for companies that manufacture, distribute, and sell physical goods, including supply chain management, inventory and logistics tools, and retail point-of-sale and digital commerce systems. Its solutions serve manufacturing, distribution, and retail businesses across their supply chains.

1 investor

2 investors

EpicQuest Education Group provides university pathway and college preparation services for domestic and international students seeking degree programs in the US, Canada, and UK. The company owns or partners with educational institutions including Davis University in Ohio and EduGlobal College in Canada, while acting as a recruiting agent for regional universities.

0 investors

Epic CRISPR develops GEMS (Gene Expression Modulation System), a modular epigenetic editing platform that combines DNA-binding proteins, guide RNAs, and modulator proteins to create genetic medicines. The company serves the biotech/medtech sector with advanced tools for precise gene expression control and disease treatment.

1 investor

EpiCrop Technologies applies epigenetic research to improve crop yields and resilience through natural crop vigor enhancement. The company serves agricultural breeding and crop production partners seeking higher-performing crop varieties.

0 investors

EPICS Therapeutics develops RNA epigenetics-based cancer treatments, focusing on METTL3 inhibitors for cancers including non-small cell lung cancer, pancreatic cancer, ovarian cancer, and colorectal cancer where existing therapies are insufficient.

2 investors

EPICS is a biotech company developing plant biology and protein engineering technology to produce agricultural inputs such as crop protection products and biostimulants. It applies plant molecular farming and epigenetics research to create scalable expression systems for high-value protein production in agriculture.

2 investors

Epicurate, headquartered in Dundee, runs a hospitality platform for booking and coordinating luxury travel and lifestyle experiences. Independent providers use it to manage their operations and distribute their offerings through connected hospitality marketplaces.

1 investor

0 investors

Epicured is a healthcare food company offering medically-tailored, Low FODMAP meals designed by clinicians and prepared by chefs to address digestive conditions such as IBS, IBD, Crohn's, Colitis, and SIBO. It provides a menu of over 150 made-to-order, dietitian-approved items delivered to consumers managing chronic digestive health issues.

2 investors

Epicurus is a restaurant and live music venue in Denmark that combines Nordic cuisine with cocktails and curated jazz performances. The establishment brings together culinary and musical talent to create an integrated dining, drinking, and entertainment experience.

1 investor

0 investors

Epidarex is a venture capital firm that invests equity in early-stage life science and health technology companies, particularly university spin-outs and startups in under-ventured research hubs across the UK and US. The firm leverages its network of scientists, industry executives, and regulatory experts to support portfolio companies in translating research into commercial healthcare businesses.

2 investors

Epidutech develops an AI-powered surgical navigation platform for spine surgery that uses a patented "magnetic camera" attached to the patient's body to track a permanent magnet embedded in surgical tools in real time. It targets hospitals, clinics, and Ambulatory Surgery Centers (ASCs), replacing bulky hardware-based navigation with a compact, brand-agnostic software approach.

1 investor

EPIEN Medical develops a proprietary chemical desiccation-based debridement platform for treating impaired skin tissue and managing wounds, burns, and oral disease. The company serves healthcare professionals and veterinary practitioners globally.

0 investors

EpiEndo Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapies for chronic respiratory diseases such as COPD, based on research into macrolides and their effects on the lung epithelium. Its lead program, EP395 (glasmacinal), is a non-antibacterial macrolide with anti-inflammatory activity that is Phase 2b ready.

1 investor

EpiEP develops the EpiAccess System, a pressure-guided needle used with standard fluoroscopy to give physicians real-time confirmation of access into the pericardial cavity for epicardial heart procedures. The technology supports treatments such as ventricular tachycardia, atrial fibrillation, and left atrial appendage ligation, and serves cardiac electrophysiologists and interventional cardiologists.

1 investor

0 investors

Epigamia creates healthier snacking options using fresh, locally-sourced ingredients, combining Indian and Greek culinary traditions. The company focuses on eliminating preservatives and artificial flavors while maintaining taste and nutrition.

1 investor

Epigene Labs develops AI-powered tools for analyzing genomic data and precision oncology research, serving biopharmaceutical companies and cancer researchers. The company builds software platforms and conducts translational research to support the development of personalized cancer therapies.

2 investors

Epigenica is a life sciences company working in multi-omics, biomarker discovery, and diagnostics. It develops advanced technologies for the life science and healthcare sectors.

2 investors

Epigenic Therapeutics develops gene regulation-based biotherapeutics using its EPIREG platform, which applies AI algorithms to design CRISPR-Cas components that regulate target gene expression without altering the DNA sequence. Combined with a lipid nanoparticle delivery system, the technology targets metabolic, cardiovascular, viral hepatitis, ocular, oncology and rare diseases.

2 investors